Home  |  繁體  |  簡体
       
  Bloomage BioTechnology Corporation Limited was incorporated in Caymans Island on 3 April 2006. It holds 100% equity interest of two companies – Valuerank Holdings Limited and Farstar Enterprises Limited – which were both incorporated in the British Virgin Islands. ...more  

Annual Report

 
04-05-2017
 

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2017

26-04-2017
 

Announcements and Notices - Notice of Annual General Meeting

26-04-2017
 

Circulars - Renewal of General Mandates to Issue New Shares and Buy-back Shares, Declaration of Final Dividend, Retirement of Directors and Re-election of Retiring Directors and Notice of Annual General Meeting

 
HA End Products - Medical device products
The injectable hyaluronan soft tisse filling gel (Trademark: BioHyalux) is the end product the Group launched in the market in 2012. Also, we have reserved products known as the medical use sodium hyaluronate gel (Trademark: HYMOIS) and the intra-articular injection (Trademark: Hyprojoint) and so forth.
To learn more……
HA Raw Materials
The HA Materials are produced by microbial fermentation, using non-genetically modified strains from non-animal sources. The products are safe, pure and stable.
To learn more……
Links to related companies
Bloomage Freda Biopharm Co., Ltd
Beijing Bloomage Hyinc Technology Co., Ltd